Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Conte

Showing results (231-240 of 368) with videos related to

Pageof 37
Sort By:
Cellular and Molecular Life Sciences : CMLS|April 25, 2007
How do Shp2 mutations that oppositely influence its biochemical activity result in syndromes with overlapping symptoms?T Edouard, A Montagner, M Dance, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Thymidine labelling index as prognostic factor in resected non-small cell lung cancerA Alama, M Costantini, L Repetto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recurrent ovarian carcinoma: salvage treatment with platinum in patients responding to first-line platinum-based regimensS Chiara, E Campora, L Merlini, et al.
Nephron|January 1, 1986
Recurrent hemolytic uremic syndrome: case reportM Meroni, A Volpi, G Battini, et al.
Oncology|January 1, 1987
Multimodality treatment of locally advanced breast cancerR Lionetto, P Pronzato, P F Conte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative GroupP F Conte, J Latreille, L Mauriac, et al.
Seminars in Oncology|June 1, 1994
Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: a phase II study in stage IIIB-IV non-small cell lung cancerE Baldini, C Tibaldi, A Chella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Continuous-infusion 5-fluorouracil in metastatic colorectal cancer patients pretreated with bolus 5-fluorouracil: clinical evidence of incomplete cross-resistanceA Falcone, C Cianci, E Pfanner, et al.
Annals of the New York Academy of Sciences|November 30, 1993
Evaluation of taxol cardiotoxicity in metastatic breast cancerO Biadi, G Mengozzi, G Gherarducci, et al.
British Journal of Cancer|November 27, 2001
Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC)E Baldini, A Ardizzoni, T Prochilo, et al.
Pageof 37

Showing results (231-240 of 368) with videos related to

Sort By:
Pageof 37
Cellular and Molecular Life Sciences : CMLS|April 25, 2007
How do Shp2 mutations that oppositely influence its biochemical activity result in syndromes with overlapping symptoms?T Edouard, A Montagner, M Dance, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Thymidine labelling index as prognostic factor in resected non-small cell lung cancerA Alama, M Costantini, L Repetto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recurrent ovarian carcinoma: salvage treatment with platinum in patients responding to first-line platinum-based regimensS Chiara, E Campora, L Merlini, et al.
Nephron|January 1, 1986
Recurrent hemolytic uremic syndrome: case reportM Meroni, A Volpi, G Battini, et al.
Oncology|January 1, 1987
Multimodality treatment of locally advanced breast cancerR Lionetto, P Pronzato, P F Conte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative GroupP F Conte, J Latreille, L Mauriac, et al.
Seminars in Oncology|June 1, 1994
Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: a phase II study in stage IIIB-IV non-small cell lung cancerE Baldini, C Tibaldi, A Chella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Continuous-infusion 5-fluorouracil in metastatic colorectal cancer patients pretreated with bolus 5-fluorouracil: clinical evidence of incomplete cross-resistanceA Falcone, C Cianci, E Pfanner, et al.
Annals of the New York Academy of Sciences|November 30, 1993
Evaluation of taxol cardiotoxicity in metastatic breast cancerO Biadi, G Mengozzi, G Gherarducci, et al.
British Journal of Cancer|November 27, 2001
Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC)E Baldini, A Ardizzoni, T Prochilo, et al.
Pageof 37